Biotech Archives - Page 679 of 733

3 minute read

Aeterna Zentaris Set To Regain Full Rights To Macrilen In U.S. And Canada From Novo Nordisk

August 29, 8:06 AM

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced

AEZS

2 minute read

Alnylam Reports Results From Phase 2 Study Of Investigational Cemdisiran For The Treatment Of IgA Nephropathy; Co Reports ‘Cemdisiran Was Generally Well-Tolerated in Patients with IgA Nephropathy’

By Benzinga Newsdesk

August 29, 8:04 AM

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) today announced positive results from a Phase 2 study of cemdisiran, an investigational RNAi therapeutic targeting the C5 component of the complement pathway, in development in

ALNY

1 minute read

Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers

By Vandana Singh

August 29, 7:16 AM

Amarin Corporation plc (NASDAQ:AMRN) announced that new REDUCE-IT data show that Vascepa/Vazkepa (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients…

AMRN

3 minute read

Recap Of Friday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 26, 7:52 PM

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor…

BCRX

1 minute read

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed

By Vandana Singh

August 26, 1:15 PM

According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be…

AEMD

1 minute read

Biomea Fusion Touts Additional Preclinical Data For Blood Cancer Candidate

By Vandana Singh

August 26, 1:13 PM

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of two posters at the 19th International Myeloma Society (IMS) Annual Meeting.

BMEA

1 minute read

Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents

By Vandana Singh

August 26, 12:46 PM

The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine, Nuvaxovid…

NVAX

1 minute read

Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine

By Vandana Singh

August 26, 12:41 PM

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the European Medicines Agency (EMA) for a booster dose of an…

BNTX

1 minute read

Amarin’s New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes

By Vandana Singh

August 26, 12:08 PM

New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes in patients with cardiovascular disease or diabetes with risk factors.

AMRN